Create

San Francisco, US · Founded 2020 · 3 known investors

CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.

BiotechDigital HealthHealthtechMedical Devicesin /createmedicines @CREATEMedicines

Founders & leadership

Daniel GettsinFounder and CEO

Brett KaplaninChief Financial and Business Officer

Marcus LoweExecutive Officer, Director

Dhruv AminExecutive Officer, Director

Investors · 3

8VCAustin · $500K – $50M

Raptor GroupMiami Beachvia Jim Pallotta · inferred

Newpath PartnersreportedBoston · $50K – $10M

Reported raises · per SEC filings

Form D private placements

▶$2MraisedNov 2022 · 1 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Marcus LoweExecutive Officer, Director
Dhruv AminExecutive Officer, Director

Offering amount: $3M
Amount sold: $2M
First sale: Nov 2022
Incorporated: Corporation, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.